Liu N - Search Results

1

Methionine enkephalin (MENK) suppresses lung cancer by regulating the Bcl-2/Bax/caspase-3 signaling pathway and enhancing natural killer cell-driven tumor immunity.

Zhang S, Liu N, Ma M, Huang H, Handley M, Bai X, Shan F. Zhang S, et al. Among authors: liu n. Int Immunopharmacol. 2021 Sep;98:107837. doi: 10.1016/j.intimp.2021.107837. Epub 2021 Jun 8. Int Immunopharmacol. 2021. PMID: 34116288

2

Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo.

Liu N, Ma M, Qu N, Wang R, Chen H, Hu F, Gao S, Shan F. Liu N, et al. Int Immunopharmacol. 2020 Sep;86:106718. doi: 10.1016/j.intimp.2020.106718. Epub 2020 Jun 22. Int Immunopharmacol. 2020. PMID: 32585612

3

Strategic enhancement of immune checkpoint inhibition in refractory Colorectal Cancer: Trends and future prospective.

Liu N, Shan F, Ma M. Liu N, et al. Int Immunopharmacol. 2021 Oct;99:108017. doi: 10.1016/j.intimp.2021.108017. Epub 2021 Aug 2. Int Immunopharmacol. 2021. PMID: 34352568 Review.

4

Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor.

Qu N, Wang R, Meng Y, Liu N, Zhai J, Shan F. Qu N, et al. Among authors: liu n. Int Immunopharmacol. 2022 Sep;110:108933. doi: 10.1016/j.intimp.2022.108933. Epub 2022 Jun 20. Int Immunopharmacol. 2022. PMID: 35738090

5

Novel effect of methionine enkephalin against influenza A virus infection through inhibiting TLR7-MyD88-TRAF6-NF-κB p65 signaling pathway.

Tian J, Jiao X, Wang X, Geng J, Wang R, Liu N, Gao X, Griffin N, Shan F. Tian J, et al. Among authors: liu n. Int Immunopharmacol. 2018 Feb;55:38-48. doi: 10.1016/j.intimp.2017.12.001. Epub 2017 Dec 22. Int Immunopharmacol. 2018. PMID: 29220721

6

Rules to activate CD8⁺T cells through regulating subunits of opioid receptors by methionine enkephalin (MENK).

Jiao X, Wang X, Wang R, Geng J, Liu N, Chen H, Griffin N, Shan F. Jiao X, et al. Among authors: liu n. Int Immunopharmacol. 2018 Dec;65:76-83. doi: 10.1016/j.intimp.2018.09.040. Epub 2018 Oct 2. Int Immunopharmacol. 2018. PMID: 30290369

7

Novel modulation on myeloid-derived suppressor cells (MDSCs) by methionine encephalin (MENK).

Geng J, Yuan Y, Jiao X, Wang R, Liu N, Chen H, Griffin N, Shan F. Geng J, et al. Among authors: liu n. Int Immunopharmacol. 2019 Mar;68:193-203. doi: 10.1016/j.intimp.2019.01.012. Epub 2019 Jan 15. Int Immunopharmacol. 2019. PMID: 30654309

8

Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway.

Ma M, Wang X, Liu N, Shan F, Feng Y. Ma M, et al. Among authors: liu n. Int Immunopharmacol. 2020 Jun;83:106388. doi: 10.1016/j.intimp.2020.106388. Epub 2020 Mar 11. Int Immunopharmacol. 2020. PMID: 32171145

9

Low-dose naltrexone plays antineoplastic role in cervical cancer progression through suppressing PI3K/AKT/mTOR pathway.

Liu N, Yan L, Shan F, Wang X, Qu N, Handley MK, Ma M. Liu N, et al. Transl Oncol. 2021 Apr;14(4):101028. doi: 10.1016/j.tranon.2021.101028. Epub 2021 Feb 1. Transl Oncol. 2021. PMID: 33540155 Free PMC article.

10

The novel mechanism of anticancer effect on gastric cancer through inducing G0/G1 cell cycle arrest and caspase-dependent apoptosis in vitro and in vivo by methionine enkephalin.

Wang X, Tian J, Jiao X, Geng J, Wang R, Liu N, Gao X, Griffin N, Gao Y, Shan F. Wang X, et al. Among authors: liu n. Cancer Manag Res. 2018 Oct 18;10:4773-4787. doi: 10.2147/CMAR.S178343. eCollection 2018. Cancer Manag Res. 2018. PMID: 30425572 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,011 results

Search Page

Filters